Giuseppe G.
- Country
- Italy
- Department
- Translational Medicine and Surgery
Research Overview
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Long-term safety and tolerability of zigakibart in adults with primary IgA nephropathy: an open-label extension study
- Evaluation of Pegcetacoplan for Reducing Proteinuria in Adults and Adolescents with Focal Segmental Glomerulosclerosis
Data & Insights
Has run more than one trial at 193 of 673 partner sites.
Specializations
Glomerular Diseases
The investigator specializes in treating various forms of glomerulonephritis, with particular emphasis on IgA Nephropathy and focal segmental glomerulosclerosis. Their research extends to innovative therapeutic approaches for rapidly progressive glomerulonephritis.
- Primary IgA Nephropathy management
- Focal Segmental Glomerulosclerosis treatment
- Rapidly Progressive Glomerular Disease interventions
Kidney Disease Management
Focuses on comprehensive treatment approaches for chronic kidney disease and associated conditions, including hypertension and end-stage kidney disease. The investigator has particular interest in autosomal dominant polycystic kidney disease.
- Non-diabetic chronic kidney disease
- Hypertension in kidney disease
- Polycystic kidney disease therapeutics
Specialized Conditions
Expert in treating rare and complex conditions including atypical hemolytic uremic syndrome and transplant rejection. The investigator works with novel therapeutic approaches for these challenging disorders.
- Atypical Hemolytic Uremic Syndrome treatment
- Antibody-mediated rejection prevention
- Cardiovascular complications in kidney disease
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.